ASSURE vs. S-TRAC: conflicting results of adjuvant treatments for kidney cancer in the era of targeted agents and genomics

Ann Transl Med. 2016 Oct;4(Suppl 1):S14. doi: 10.21037/atm.2016.10.45.

Authors

Camillo Porta¹, Silvia Chiellino²

Affiliations

¹ Medical Oncology, I.R.C.C.S. San Matteo University Hospital Foundation, Pavia, Italy; ; Italian Group of Onco-Nephrology (Gruppo Italiano di Oncologia Nefrologica/GION), Pavia, Italy.
² Medical Oncology, I.R.C.C.S. San Matteo University Hospital Foundation, Pavia, Italy.

No abstract available

Publication types

Editorial
Comment